Daniel J. Lippis, CVP, TAVR at Edwards Lifesciences Corp (EW), sold 619 shares at $87.51 ($54K) on 2026-09-11, disclosed to the SEC on 2026-09-11.
Scheduled sale ($54k) by CVP, TAVR under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |
| EW | SELL | 2026-05-18 | $50K | — | Filing → |